PremiumCompany AnnouncementsSERAFA-1 Trial Update: AstraZeneca and Icon Deepen Their Breast Cancer Bet11h agoICLR
PremiumCompany AnnouncementsAstraZeneca’s Embold Trial Signals a Big Push Into the Obesity Drug Race11h agoAZN